Cargando…
Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study
The standard treatment of primary hypoparathyroidism (hypoPT) with oral calcium supplementation and calcitriol (or an analog), intended to control hypocalcemia and hyperphosphatemia and avoid hypercalciuria, remains challenging for both patients and clinicians. In 2015, human parathyroid hormone (hP...
Autores principales: | Ish‐Shalom, Sofia, Caraco, Yoseph, Khazen, Nariman Saba, Gershinsky, Michal, Szalat, Auryan, Schwartz, Phillip, Arbit, Ehud, Galitzer, Hillel, Tang, Jonathan CY, Burshtein, Gregory, Rothner, Ariel, Raskin, Arthur, Blum, Miriam, Fraser, William D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252608/ https://www.ncbi.nlm.nih.gov/pubmed/33666947 http://dx.doi.org/10.1002/jbmr.4274 |
Ejemplares similares
-
The combined effect of permeation enhancement and proteolysis inhibition on the systemic exposure of orally administrated peptides: Salcaprozate sodium, soybean trypsin inhibitor, and teriparatide study in pigs
por: Burshtein, Gregory, et al.
Publicado: (2021) -
Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone
por: Rejnmark, Lars, et al.
Publicado: (2015) -
Therapy of Hypoparathyroidism by Replacement with Parathyroid Hormone
por: Rejnmark, Lars, et al.
Publicado: (2014) -
The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells
por: Galitzer, Hillel, et al.
Publicado: (2009) -
Quality of Life in Post-Surgical Hypoparathyroidism (PoSH) in Thyroid and Parathyroid Surgery
por: Hillary, Sarah L., et al.
Publicado: (2022)